Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:10553069rdf:typepubmed:Citationlld:pubmed
pubmed-article:10553069lifeskim:mentionsumls-concept:C0017349lld:lifeskim
pubmed-article:10553069lifeskim:mentionsumls-concept:C1185625lld:lifeskim
pubmed-article:10553069lifeskim:mentionsumls-concept:C0031715lld:lifeskim
pubmed-article:10553069lifeskim:mentionsumls-concept:C0033634lld:lifeskim
pubmed-article:10553069lifeskim:mentionsumls-concept:C0063356lld:lifeskim
pubmed-article:10553069lifeskim:mentionsumls-concept:C0599896lld:lifeskim
pubmed-article:10553069lifeskim:mentionsumls-concept:C0851285lld:lifeskim
pubmed-article:10553069pubmed:issue10lld:pubmed
pubmed-article:10553069pubmed:dateCreated1999-12-2lld:pubmed
pubmed-article:10553069pubmed:abstractTextThe invariant chain (Ii) plays a critical role in the transport of newly synthesized class II molecules to endosomal Ag-processing compartments. Of the two major isoforms of human Ii, only Ii-p35 is phosphorylated in vivo, and inhibiting Ii phosphorylation inhibits the trafficking of newly synthesized class II molecules to Ag-processing compartments. We now report that a member of the protein kinase C family of serine/threonine kinases is responsible for the constitutive phosphorylation of 50% of the total cellular pool of Ii-p35 in a wide variety of APCs, including B lymphocytes, PBMC, immature dendritic cells, and mature dendritic cells. Stimulation of protein kinase C activity in APCs significantly enhanced the kinetics of degradation of class II-associated Ii in Ag-processing compartments and the binding of antigenic peptides to these class II molecules. In cells expressing an Ii-phosphorylation mutant, trafficking of class II molecules to endosomes was impaired and Ii proteolysis was inhibited, demonstrating a direct effect of Ii phosphorylation on MHC class II trafficking. These results demonstrate that phosphorylation of Ii in APCs alters the kinetics of trafficking of newly synthesized class II molecules to lysosomal Ag-processing compartments.lld:pubmed
pubmed-article:10553069pubmed:languageenglld:pubmed
pubmed-article:10553069pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10553069pubmed:citationSubsetAIMlld:pubmed
pubmed-article:10553069pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10553069pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10553069pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10553069pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10553069pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10553069pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10553069pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10553069pubmed:statusMEDLINElld:pubmed
pubmed-article:10553069pubmed:monthNovlld:pubmed
pubmed-article:10553069pubmed:issn0022-1767lld:pubmed
pubmed-article:10553069pubmed:authorpubmed-author:KawamuraTTlld:pubmed
pubmed-article:10553069pubmed:authorpubmed-author:AndersonH AHAlld:pubmed
pubmed-article:10553069pubmed:authorpubmed-author:RocheP APAlld:pubmed
pubmed-article:10553069pubmed:authorpubmed-author:BlauveltAAlld:pubmed
pubmed-article:10553069pubmed:authorpubmed-author:BergstralhD...lld:pubmed
pubmed-article:10553069pubmed:issnTypePrintlld:pubmed
pubmed-article:10553069pubmed:day15lld:pubmed
pubmed-article:10553069pubmed:volume163lld:pubmed
pubmed-article:10553069pubmed:ownerNLMlld:pubmed
pubmed-article:10553069pubmed:authorsCompleteYlld:pubmed
pubmed-article:10553069pubmed:pagination5435-43lld:pubmed
pubmed-article:10553069pubmed:dateRevised2007-11-15lld:pubmed
pubmed-article:10553069pubmed:meshHeadingpubmed-meshheading:10553069...lld:pubmed
pubmed-article:10553069pubmed:meshHeadingpubmed-meshheading:10553069...lld:pubmed
pubmed-article:10553069pubmed:meshHeadingpubmed-meshheading:10553069...lld:pubmed
pubmed-article:10553069pubmed:meshHeadingpubmed-meshheading:10553069...lld:pubmed
pubmed-article:10553069pubmed:meshHeadingpubmed-meshheading:10553069...lld:pubmed
pubmed-article:10553069pubmed:meshHeadingpubmed-meshheading:10553069...lld:pubmed
pubmed-article:10553069pubmed:meshHeadingpubmed-meshheading:10553069...lld:pubmed
pubmed-article:10553069pubmed:meshHeadingpubmed-meshheading:10553069...lld:pubmed
pubmed-article:10553069pubmed:meshHeadingpubmed-meshheading:10553069...lld:pubmed
pubmed-article:10553069pubmed:meshHeadingpubmed-meshheading:10553069...lld:pubmed
pubmed-article:10553069pubmed:meshHeadingpubmed-meshheading:10553069...lld:pubmed
pubmed-article:10553069pubmed:meshHeadingpubmed-meshheading:10553069...lld:pubmed
pubmed-article:10553069pubmed:meshHeadingpubmed-meshheading:10553069...lld:pubmed
pubmed-article:10553069pubmed:meshHeadingpubmed-meshheading:10553069...lld:pubmed
pubmed-article:10553069pubmed:meshHeadingpubmed-meshheading:10553069...lld:pubmed
pubmed-article:10553069pubmed:year1999lld:pubmed
pubmed-article:10553069pubmed:articleTitlePhosphorylation of the invariant chain by protein kinase C regulates MHC class II trafficking to antigen-processing compartments.lld:pubmed
pubmed-article:10553069pubmed:affiliationExperimental Immunology Branch, National Cancer Institute, Bethesda, MD 20892, USA.lld:pubmed
pubmed-article:10553069pubmed:publicationTypeJournal Articlelld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10553069lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10553069lld:pubmed